Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1390672
PUBLISHER: IMARC | PRODUCT CODE: 1390672
Recombinant DNA Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Abstract
The global recombinant DNA technology market size reached US$ 729.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 966.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.80% during 2022-2028.
The advent of recombinant DNA technology has revolutionized development in biology and offered new opportunities for innovations. Also known as genetic engineering, it is currently widely used to alter genetic material outside an organism and obtain improved and desired characteristics in living organisms. It includes the insertion of DNA fragments from several sources that have a desirable gene sequence through an appropriate vector. Besides this, it assists in the safe, affordable, and sufficient production of vital proteins required for dietary purposes and fighting health problems. As a result, it has multidisciplinary applications and a remarkable potential to improve health and enhance food resources and resistance to divergent adverse environmental effects.
Recombinant DNA Technology Market Trends:
The recombinant DNA technology is utilized for improving different health conditions, mainly by developing new vaccines and pharmaceuticals. This, coupled with the improving treatment strategies on account of the developing diagnostics kits, monitoring devices, and new therapeutic approaches, represents one of the key factors impelling the growth of the market. Moreover, there is a rise in the research conducted on genetically modified organisms (GMO), which include microorganisms that are considered as bio degraders and clean fuel producers. This can be accredited to rapid urbanization, growing global population, reducing arable land, considerable rising food shortage and increasing adoption of GMO crops. Apart from this, as recombinant DNA technology offers several innovation opportunities to develop a vast range of therapeutic products with immediate effect in medical genetics and biomedicine, its application is expanding in various sectors. For instance, the integration of recombinant DNA technology with effective gene therapy for replacing the defective gene with normal ones and the production of antigen-specific antibodies for clinical research, studies, and disease diagnosis, are anticipated to drive the market growth in the upcoming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant DNA technology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, component, application and end user.
Breakup by Product:
Medical
Therapeutic Agent
Human Protein
Vaccines
Non-Medical
Biotech Crops
Specialty Chemicals
Others
Breakup by Component:
Expression System
Cloning Vector
Breakup by Application:
Food and Agriculture
Health and Disease
Environment
Others
Breakup by End User:
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A and Syngene International Ltd (Biocon Limited).
Key Questions Answered in This Report:
- How has the global recombinant DNA technology market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global recombinant DNA technology market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the component?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global recombinant DNA technology market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112023A4484
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Recombinant DNA Technology Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Medical
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Therapeutic Agent
- 6.1.2.2 Human Protein
- 6.1.2.3 Vaccines
- 6.1.3 Market Forecast
- 6.2 Non-Medical
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Biotech Crops
- 6.2.2.2 Specialty Chemicals
- 6.2.2.3 Others
- 6.2.3 Market Forecast
7 Market Breakup by Component
- 7.1 Expression System
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Cloning Vector
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Food and Agriculture
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Health and Disease
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Environment
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by End User
- 9.1 Biotechnology and Pharmaceutical Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Academic and Government Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Amgen Inc
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Cibus
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 F.Hoffmann-La Roche Ltd
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 SWOT Analysis
- 15.3.4 GenScript
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 GlaxoSmithKline plc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Horizon Discovery Group plc
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Merck KGaA
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 New England Biolabs
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Novo Nordisk A/S
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Pfizer Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Sanofi S.A
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 Syngene International Ltd (Biocon Limited)
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.1 Amgen Inc
Product Code: SR112023A4484
List of Figures
- Figure 1: Global: Recombinant DNA Technology Market: Major Drivers and Challenges
- Figure 2: Global: Recombinant DNA Technology Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Recombinant DNA Technology Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Recombinant DNA Technology Market: Breakup by Product (in %), 2022
- Figure 5: Global: Recombinant DNA Technology Market: Breakup by Component (in %), 2022
- Figure 6: Global: Recombinant DNA Technology Market: Breakup by Application (in %), 2022
- Figure 7: Global: Recombinant DNA Technology Market: Breakup by End User (in %), 2022
- Figure 8: Global: Recombinant DNA Technology Market: Breakup by Region (in %), 2022
- Figure 9: Global: Recombinant DNA Technology (Medical) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Recombinant DNA Technology (Medical) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Recombinant DNA Technology (Non-Medical) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Recombinant DNA Technology (Non-Medical) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Recombinant DNA Technology (Expression System) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Recombinant DNA Technology (Expression System) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Recombinant DNA Technology (Cloning Vector) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Recombinant DNA Technology (Cloning Vector) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Recombinant DNA Technology (Food and Agriculture) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Recombinant DNA Technology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Recombinant DNA Technology (Health and Disease) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Recombinant DNA Technology (Health and Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Recombinant DNA Technology (Environment) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Recombinant DNA Technology (Environment) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Recombinant DNA Technology (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Recombinant DNA Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: Global: Recombinant DNA Technology (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: Global: Recombinant DNA Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: North America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: North America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: United States: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: United States: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Canada: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Canada: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: Asia-Pacific: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: Asia-Pacific: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: China: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: China: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: Japan: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: Japan: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: India: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: India: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: South Korea: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: South Korea: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: Australia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: Australia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: Indonesia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: Indonesia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: Europe: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: Europe: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: Germany: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: Germany: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: France: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: France: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: United Kingdom: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: United Kingdom: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: Italy: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: Italy: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Spain: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Spain: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: Russia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: Russia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Latin America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Latin America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Brazil: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Brazil: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Mexico: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: Mexico: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Middle East and Africa: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
- Figure 78: Middle East and Africa: Recombinant DNA Technology Market: Breakup by Country (in %), 2022
- Figure 79: Middle East and Africa: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 80: Global: Recombinant DNA Technology Industry: SWOT Analysis
- Figure 81: Global: Recombinant DNA Technology Industry: Value Chain Analysis
- Figure 82: Global: Recombinant DNA Technology Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Recombinant DNA Technology Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Recombinant DNA Technology Market Forecast: Breakup by Product (in Million US$), 2023-2028
- Table 3: Global: Recombinant DNA Technology Market Forecast: Breakup by Component (in Million US$), 2023-2028
- Table 4: Global: Recombinant DNA Technology Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 5: Global: Recombinant DNA Technology Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 6: Global: Recombinant DNA Technology Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 7: Global: Recombinant DNA Technology Market: Competitive Structure
- Table 8: Global: Recombinant DNA Technology Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.